Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-06-25

Clinical Trial Update: Prevacid vs Lifestyle Modifications for the Treatment of LPR [NA]

View source ↗

Summary

This clinical trial update compares lansoprazole (Prevacid) with lifestyle modifications for the treatment of Laryngopharyngeal Reflux, with the current status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREVACID (LANSOPRAZOLE)

Snippet

Sponsor: Hodge, Kenneth M., M.D. | Conditions: Laryngopharyngeal Reflux | NA | Status: UNKNOWN